| Name | Title | Contact Details |
|---|---|---|
Gregory Dickson |
Sr. VP, Global Quality and Regulatory Compliance | Profile |
Quotient Sciences is a drug development and manufacturing accelerator supporting customers from candidate selection to commercial launch.
A discovery through early clinical phase pharmaceutical company, Ratio Therapeutics employs a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancer. Ratio Therapeutics` Trillium™ targeting scaffold combines pharmacokinetic modulation with best-in-class chelation technology to create proprietary small molecule targeting agents to attack a broad array of cancer targets. Our compounds accommodate imaging and therapeutic radioisotopes, ie "theranostics". The tunable nature of our platform combined with small-scale imaging trials in patients results in accelerated, de-risked compound selection.
OSO BioPharmaceuticals Manufacturing is a Albuquerque, NM-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Seamlessly integrating patient-specific surgical planning and navigation, professional education and rehearsal experiences with incredible VR-empowered patient engagement capabilities
Roxane Laboratories is a Columbus, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.